Navigation Links
Cardia 7 Pleased to Announce its Cholesterol Reducing Purified Omega 7
Date:12/9/2013

CLEVELAND, Ohio, Dec. 9, 2013 /PRNewswire-iReach/ -- Cardia 7 today announces its purified Omega-7 product, Cardia 7, is now available. The new product, which contains the Omega 7 Fatty Acid (or Palmitoleic Acid), is proving to have excellent cardiovascular and other health benefits, even over Omega 3. Clinical studies suggest that purified Omega 7 lowers triglycerides, bad cholesterol (LDL), and C-Reactive Protein (CRP) while increasing good cholesterol (HDL) and lipid profiles. It also decreases insulin resistance, weight, chronic and acute inflammation, and hepatic fat accumulation, without side effects.

(Photo: http://photos.prnewswire.com/prnh/20131209/MN29957)

"We are seeing amazing benefits from this fatty acid. Research is proving that purified Omega-7 has even more substantial benefits over Omega 3. Just one softgel a day could reduce plaque in arteries, boost HDL, and improve insulin sensitivity and glucose metabolism," said Arnold Mausser, a representative from Cardia 7.

This essential fatty acid is found in plant and animal sources, especially in fish oil, and macadamia nuts. However, for positive benefits of Omega 7, palmitoleic acid (Omega 7) has to be purified from the saturated fatty acid, palmitic acid, which is always conjoined with palmitoleic acid (Omega 7) in its original source. Without a completely purified state, people could potentially experience negative health benefits from taking it. 

Cardia 7 is made with the most purified palmitoleic acid (Omega 7). It undergoes a 7-step purification process that expresses high levels of palmitoleic acid (C16:1n7) from fish oil while also removing the saturated fatty acid, palmitic acid (equivalent to trans-fat) to less than 1% which creates a (Palmitric Free) purified Omega-7.  Cardia 7 is the most pure source of Omega-7 fatty acids on the market.   When analyzing omega 7 products on the market, be sure to pay attention to the amount of palmitic acid in the product.  If it is over 1% it is not palmitic free, thus you will be consuming the equivalence of trans fat.

"This is good news. Cardia 7 can help in the fight against cardiovascular disease, such as those who have been diagnosed with cardiac risk factors, diabetes, and even weight management. No other natural product can say it has this much punch when it comes to fighting a variety of diseases," said Mausser.

Cardia 7 is only one of a select few who sell the purified form of Omega 7.  Since introducing Omega 7's extraordinary health benefits, many consumers are wanting to try this incredible fatty acid. It makes sense that clinics, holistic and wellness centers begin to carry the product as well," said Mausser.

About Cardia 7

Cardia 7 is a brand new product distributed online or at the Cleveland Clinic Wellness Center. It is one of the few products on the market that uses a patent-pending 7-step purification process to express high levels of the monosaturated fatty acid, palmitoleic acid (C16:1n7) or Omega 7, from fish oil while also removing the saturated fatty acid, palmitic acid reducing it to below 1% making it (Palmitic Free).

To order, go to Cardia 7's website at www.cardia7.com.

Media Contact: Jim Thrash, Cardia7, 440-550-4355, info@cardia7.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Cardia 7
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Case Report Published in the Journal Perfusion on 14-Year-Old Pediatric Patient Bridged to Transplant with SynCardia Total Artificial Heart
2. A Record 125 SynCardia Total Artificial Hearts Implanted by Surgeons Worldwide So Far in 2013
3. UK’s 1st SynCardia Total Artificial Heart Patient Bridged to Transplant at Papworth Hospital
4. Journal of Cardiothoracic Surgery Publishes 1st Case Report of Using Single-Site Cannulation ECMO to Treat SynCardia Total Artificial Heart Patient
5. French Man Surpasses Two Years of Support with SynCardia Total Artificial Heart
6. Over 50% of “Best Heart Hospitals” in U.S. News & World Report Are Certified to Implant the SynCardia Total Artificial Heart
7. 1st Pediatric SynCardia Total Artificial Heart Patient in Turkey Celebrates 18th Birthday
8. SynCardia Total Artificial Heart Surpasses 100th Implant of 2013
9. SynCardia Total Artificial Heart Bridges Mother of Four with Congenital Heart Defect & Biventricular Heart Failure to Transplant
10. Medical Design Excellence Awards Selects Companion 2 Hospital Driver for Powering SynCardia Total Artificial Heart as Silver Winner
11. 7 SynCardia Certified Centers Honored Among “Best Children’s Hospitals” for Cardiology and Heart Surgery by U.S. News & World Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... Feb. 3, 2016  With the growing need ... that is underway, therapies such as monoclonal antibodies, ... whole host of indications are in high demand. ... the development and production of these therapeutics. However, ... and high costs, novel approaches and novel expression ...
(Date:2/3/2016)... Feb. 3, 2016 New Jersey Health Foundation ... $1 million for researchers in New ... research that demonstrates exciting potential.   ... for the New Jersey Health Foundation Research Grant ... these educational institutions— Princeton University, Rutgers University, Rowan ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... Unix visualization solutions today announced the addition of a powerful “Session Preview” feature ... see the current state of the remote Linux desktop or other applications (sessions) ...
(Date:2/3/2016)... Calif. , Feb. 3, 2016  Today, Symphony ... of AlphaImpactRx , a leading provider of primary ... companies to IMS Health , a global information ... complementary offerings, capabilities and technologies will be integrated into ... growing global primary market research capabilities. ...
Breaking Biology Technology:
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
(Date:1/20/2016)... SAN JOSE, Calif. , Jan. 20, 2016 ... leading developer of human interface solutions, today announced ... touch controller solution for wearables and small screen ... appliances such as printers. Supporting round and rectangular ... the S1423 offers excellent performance with moisture on ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):